Cargando…

Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial

BACKGROUND: Chronic migraine is a prevalent disabling disease, with major health-related burden and poor quality of life. Long-term use of preventive medications carries risk of side effects. OBJECTIVES: The aim of this study was to compare repetitive transcranial magnetic stimulation (rTMS) to botu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shehata, Hatem S, Esmail, Eman H, Abdelalim, Ahmad, El-Jaafary, Shaimaa, Elmazny, Alaa, Sabbah, Asmaa, Shalaby, Nevin M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063492/ https://www.ncbi.nlm.nih.gov/pubmed/27785091 http://dx.doi.org/10.2147/JPR.S116671

Ejemplares similares

Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex
por: Shehata, Hatem S, et al.
Publicado: (2017)

Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
por: Shehata, Hatem S, et al.
Publicado: (2013)

Genetic Influences on Cognition in Idiopathic Parkinson's Disease
por: Amer, Hanan, et al.
Publicado: (2018)

Oromandibular Dystonia in Yemeni Patients with Khat Chewing: A Response to Botulinum Toxin Treatment
por: Shehata, Hatem S., et al.
Publicado: (2014)

Development and validation of an Arabic-language headache questionnaire for population-based surveys
por: El-Sherbiny, Naglaa A, et al.
Publicado: (2017)

Transcranial magnetic stimulation in migraine prophylaxis
por: Leahu, P, et al.
Publicado: (2018)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
por: Hamdy, Sherif M, et al.
Publicado: (2018)

The effectiveness of propranolol, flunarizine, amitriptyline and botulinum toxin in vestibular migraine complaints and prophylaxis: a non-randomized controlled study
por: Görür, Kemal, et al.
Publicado: (2021)

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

There is Value in Anecdotal Reports of Relief from Migraine with Botulinum Toxin
por: Winett, Bill
Publicado: (2009)

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin, Bo, et al.
Publicado: (2021)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
por: Elmazny, Alaa, et al.
Publicado: (2020)

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
por: Hamdy, Sherif M, et al.
Publicado: (2017)

Could SARS-CoV-2 herald a surge of multiple sclerosis?
por: Shalaby, Nevin Mohieldin, et al.
Publicado: (2021)

Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials
por: Shao, Yu-Feng, et al.
Publicado: (2013)

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine
por: Herd, Clare P, et al.
Publicado: (2019)

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
por: Hamdy, Sherif M, et al.
Publicado: (2020)

A feasible repetitive transcranial magnetic stimulation clinical protocol in migraine prevention
por: Zardouz, Shawn, et al.
Publicado: (2016)

Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis
por: Zhong, Jiugen, et al.
Publicado: (2022)

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
por: Robertson, Carrie E, et al.
Publicado: (2012)

EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine
por: Bergmans, BA, et al.
Publicado: (2014)

P042. Mechanism of action and clinical evidence of botulinum toxin in chronic migraine
por: Franco, Giovanni, et al.
Publicado: (2015)

O048. Chronic migraine, cluster headache or both? The suggestion of botulinum toxin
por: Ripa, Patrizia, et al.
Publicado: (2015)

The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review
por: Dhengare, Ayushi S, et al.
Publicado: (2022)

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era
por: Hamdy, Sherif M, et al.
Publicado: (2020)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study
por: Barrientos, Nelson, et al.
Publicado: (2003)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
por: Kępczyńska, Katarzyna, et al.
Publicado: (2022)

Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic
por: Nascimento, Henrique, et al.
Publicado: (2023)

Evaluation of the Spasticity after Botulinum Toxin Injection Using Paired-Pulse Transcranial Magnetic Stimulation
por: Chia, Chin-Hsuan, et al.
Publicado: (2018)

The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
por: Kishk, Nirmeen A., et al.
Publicado: (2021)

Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
por: Adu, Medard Kofi, et al.
Publicado: (2022)

Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines
por: Dima, Lorena, et al.
Publicado: (2019)

Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
por: Ahmed, F, et al.
Publicado: (2013)

Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
por: Naderinabi, Bahram, et al.
Publicado: (2017)

A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
por: Kim, Young-gun, et al.
Publicado: (2020)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kiu14mchjer09tuji7m82kk963